Cardiac diseases complicating community-acquired pneumonia

Current Opinion in Infectious Diseases

Volumn 27, Issue 3, 2014, Pages 295-301

  Aliberti, Stefano ^a   Ramirez, Julio A ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b University of Louisville School of Medicine   (United States)

Author keywords

acute myocardial infarction; arrhythmia; community acquired pneumonia; heart failure; stroke

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREDICTOR VARIABLE; PREVALENCE; REVIEW; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; COMMUNITY ACQUIRED INFECTION; COMPLICATION; MORTALITY; MYOCARDIAL INFARCTION; PNEUMONIA; RISK FACTOR;

ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; COMMUNITY-ACQUIRED INFECTIONS; HEART FAILURE; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; PNEUMONIA; PREVALENCE; RISK FACTORS;

EID: 84900483478     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000055     Document Type: Review

References (38)

1. World Health Organization. The Top Ten Causes of Death. www.who.int/mediacentre/factsheets/fs331.pdf Last updated: November 2013. [Accessed 4 February, 2014]
2. Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospi-talization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169:910-914.
3. Mortensen EM, Coley CM, Singer DE, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 2002; 162:1059-1064.
4. Bordon J, Wiemken T, Peyrani P, et al. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest 2010; 138:279-283.
5. Mortensen EM, Kapoor WN, Chang CC, et al. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 2003; 37:1617-1624.
6. Johnstone J, Eurich DT, Majumdar SR, et al. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore) 2008; 87:329-334.
7. Schuetz P, Christ-Crain M, Zimmerli W, Mueller B. Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia. Intensive Care Med 2011; 37:970-980.
8. Mirsaeidi M, Peyrani P, Aliberti S, et al. Thrombocytopenia and thrombocy-tosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest 2010; 137:416-420.
9. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
10. Master AM, Romanoff A, Jaffe H. Electrocardiographic changes in pneumonia. Am Heart J 1931; 6:696-709.
11. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-2618.
12. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53:481-482.
13. Clayton TC, Capps NE, Stephens NG, et al. Recent respiratory infection and the risk of myocardial infarction. Heart 2005; 91:1601-1602.
14. Lichtman JH, Spertus JA, Reid KJ, et al. Acute noncardiac conditions and in-hospital mortality in patients with acute myocardial infarction. Circulation 2007; 116:1925-1930.
15. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008; 47:182-187.
16. Musher DM, Rueda AM, Kaka AS, et al. The association between pneumo-coccal pneumonia and acute cardiac events. Clin Infect Dis 2007; 45:158-165.
17. Corrales-Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine 2009; 88:154-159.
18. Wang CC, Peng CL, Wang GJ, et al. Pneumococcal pneumonia and the risk of acute coronary syndrome: A population-based cohort study. Int J Cardiol 2013; 168:4480-4481.
19. Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 2011; 8:e1001048.
20. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010; 10:83-92.
21. Corrales-Medina VF, Musher DM, Wells GA, et al. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012;125:773-781.
22. Griffin AT, Wiemken TL, Arnold FW. Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia. Int J Infect Dis 2013; 17:e1125-e1129.
23. Viasus D, Garcia-Vidal C, Manresa F, et al. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect 2013; 66:27-33.
24. Mandal P, Chalmers JD, Choudhury G, et al. Vascular complications are associated with poor outcome in community-acquired pneumonia. QJM 2011; 104:489-495.
25. Perry TW, Pugh MJ, Waterer GW, et al. Incidence of cardiovascular events after hospital admission for pneumonia. Am J Med 2011; 124:244-251.
26. Becker T, Moldoveanu A, Cukierman T, Gerstein HC. Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabetes Res Clin Pract 2007; 78:392-397.
27. Mor A, Thomsen RW, Ulrichsen SP, Sørensen HT. Chronic heart failure and risk of hospitalization with pneumonia: A population-based study. Eur J Intern Med 2013; 24:349-353.
28. Corrales-Medina VF, Taljaard M, Fine MJ, et al. Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia. Mayo Clin Proc 2014; 89:60-68.
29. Aliberti S, Amir A, Peyrani P, et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalised patients with community-acquired pneumonia. Chest 2008; 134:955-962.
30. Yende S, D'Angelo G, Kellum JA, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008; 177:1242-1247.
31. Yende S, Angus DC, Ali IS, et al. Influence of comorbid conditions on long term mortality after pneumonia in older people. J Am Geriatr Soc 2007; 55:518-525.
32. Chang CL, Mills GD, Karalus NC, et al. Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults. PLoS One 2013;8:e62612.
33. Van Gool WA, van deBeek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 2010; 375:773-775.
34. Pieralli F, Vannucchi V, Mancini A, et al. Delirium is a predictor of in-hospital mortality in elderly patients with community acquired pneumonia. Intern Emerg Med 2014; 9:195-200.
35. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008; 121:1002-1007.
36. Khan AR, Riaz M, Bin Abdulhak AA, et al. The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS One 2013; 8:e52929.
37. Oz F, Gul S, Kaya MG, et al. Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial. Coron Artery Dis 2013; 24:231-237.
38. Théroux P. Myocardial cell protection: a challenging time for action and a challenging time for clinical research. Circulation 2000; 101:2874-2876.